Dachaigh › Aillse sa bhlaire › Michigan › Detroit
Sgrùdaidhean clionaigeach Aillse sa bhlaire ann an Detroit, MI
Tha aon sgrùdadh airson Aillse sa bhlaire a’ lorg phàirtichean aig làrach ann no faisg air Detroit. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Vanguard Study: Testing a New Way to Screen for Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
A’ fastadhÌre 2
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A’ fastadhÌre 3
- Karmanos Cancer Institute, Detroit
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
A’ fastadhÌre 1
- Barbara Ann Karmanos Cancer Institute, Detroit
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
A’ fastadhÌre 3
- Henry Ford Hospital, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Karmanos Cancer Institute, Detroit
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
A’ fastadhÌre 1/2
- Henry Ford Health System, Detroit
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
A’ fastadhÌre 2/3
- Karmanos Cancer Institute, Detroit
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A’ fastadhÌre 2
- Karmanos Cancer Institute, Detroit
- Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit
A Beta-only IL-2 ImmunoTherapY Study
A’ fastadhÌre 1/2
- Karmanos Cancer Institute, Detroit
Sgrùdaidhean Aillse sa bhlaire ann am bailtean eile
- New York City, NY35 sgrùdaidhean
- Nashville, TN31 sgrùdaidhean
- Houston, TX31 sgrùdaidhean
- Dallas, TX27 sgrùdaidhean
- Washington, DC26 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- Baltimore, MD24 sgrùdaidhean
- Los Angeles, CA24 sgrùdaidhean
- St. Louis, MO22 sgrùdaidhean
- Seattle, WA21 sgrùdaidhean
- Chicago, IL21 sgrùdaidhean
- Philadelphia, PA21 sgrùdaidhean
Sgrùdaidhean eile ann an Detroit
- Aillse Sgamhain Neo-chealla-beag44 sgrùdaidhean
- Aillse a' bhroilleach33 sgrùdaidhean
- Aillse (gach seòrsa)29 sgrùdaidhean
- Aillse colorectal26 sgrùdaidhean
- Cancer Ovarian26 sgrùdaidhean
- Ailse metastatach24 sgrùdaidhean
- Aillse Prostata22 sgrùdaidhean
- Ailse Endometrial21 sgrùdaidhean
- Ailseachadh nan Sgamhan20 sgrùdaidhean
- Myeloma iomaill19 sgrùdaidhean
- Aillse a' Bhroinn16 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil15 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.